{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T20:01:50Z","timestamp":1777060910182,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.4158\/ep-2019-0481","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T15:32:33Z","timestamp":1588001553000},"page":"722-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Safety And Efficacy Of Dpp-4 Inhibitors For The Management Of Hospitalized General Medicine And Surgery Patients with Type 2 Diabetes"],"prefix":"10.1016","volume":"26","author":[{"given":"Cristina","family":"Lorenzo-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Atienza-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Reyes-Umpierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyathama","family":"Vellanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Pasquel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumeth","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Fayfman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0481_bb0010","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"Umpierrez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0481_bb0015","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.290.15.2041","article-title":"Glucose control and mortality in critically ill patients","volume":"290","author":"Finney","year":"2003","journal-title":"JAMA"},{"key":"10.4158\/EP-2019-0481_bb0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","article-title":"Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control","volume":"31","author":"Van den Berghe","year":"2003","journal-title":"Crit Care Med"},{"key":"10.4158\/EP-2019-0481_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/014860719802200277","article-title":"Early post-operative glucose control predicts nosocomial infection rate in diabetic patients","volume":"22","author":"Pomposelli","year":"1998","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.4158\/EP-2019-0481_bb0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2337\/diacare.27.2.553","article-title":"Management of diabetes and hyperglycemia in hospitals","volume":"27","author":"Clement","year":"2004","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0481_bb0035","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/diacare.28.4.810","article-title":"The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia","volume":"28","author":"McAlister","year":"2005","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0481_bb0040","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc10-0304","article-title":"Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery","volume":"33","author":"Frisch","year":"2010","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0481_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0000000000000688","article-title":"Perioperative hyperglycemia and risk of adverse events among patients with and with-out diabetes","volume":"261","author":"Kotagal","year":"2015","journal-title":"Ann Surg"},{"key":"10.4158\/EP-2019-0481_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/SLA.0b013e31827b6bbc","article-title":"Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program","volume":"257","author":"Kwon","year":"2013","journal-title":"Ann Surg"},{"key":"10.4158\/EP-2019-0481_bb0055","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/dc18-2342","article-title":"Early intervention for diabetes in medical and surgical inpatients decreases hyperglycemia and hospital-acquired infections: a cluster randomized trial","volume":"42","author":"Kyi","year":"2019","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.4158\/EP-2019-0481_bb0060","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.2337\/dc17-S017","article-title":"14. Diabetes care in the hospital","volume":"40","author":"American Diabetes Association.","year":"2017","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0481_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0481_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jhm.390","article-title":"Evaluation of hospital glycemic control at US Academic Medical Centers","volume":"4","author":"Boord","year":"2009","journal-title":"J Hosp Med"},{"key":"10.4158\/EP-2019-0481_bb0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amjmed.2006.05.070","article-title":"Sliding scale insulin use: myth or insanity?","volume":"120","author":"Umpierrez","year":"2007","journal-title":"Am J Med."},{"key":"10.4158\/EP-2019-0481_bb0080","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/jc.2008-1441","article-title":"Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes","volume":"94","author":"Umpierrez","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0481_bb0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 Surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0481_bb0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1503\/cmaj.090206","article-title":"Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data","volume":"80","author":"Griesdale","year":"2009","journal-title":"CMAJ"},{"key":"10.4158\/EP-2019-0481_bb0095","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.2337\/dc13-0277","article-title":"Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized controlled study","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0481_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","article-title":"Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open label, non-inferiority randomised trial","volume":"5","author":"Pasquel","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.4158\/EP-2019-0481_bb0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/dom.13587","article-title":"Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: a multicentre randomized clinical trial","volume":"21","author":"Vellanki","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP-2019-0481_bb0110","doi-asserted-by":"crossref","first-page":"e000394","DOI":"10.1136\/bmjdrc-2017-000394","article-title":"Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients","volume":"5","author":"Garg","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.4158\/EP-2019-0481_bb0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/dc09-9029","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"32","author":"Moghissi","year":"2009","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0481_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11892-019-1184-8","article-title":"Debate on insulin vs non-insulin use in the hospital setting-is it time to revise the guide-lines for the management of inpatient diabetes?","volume":"19","author":"Pasquel","year":"2019","journal-title":"Curr Diab Rep."},{"key":"10.4158\/EP-2019-0481_bb0125","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N Eng J Med"},{"key":"10.4158\/EP-2019-0481_bb0130","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Eng J Med"},{"key":"10.4158\/EP-2019-0481_bb0135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Eng J Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:08:44Z","timestamp":1761516524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20360146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1530891X20360146"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0481","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety And Efficacy Of Dpp-4 Inhibitors For The Management Of Hospitalized General Medicine And Surgery Patients with Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}